retatrutide clinical trials safety efficacy Retatrutide, an experimental drug currently in Phase 3 trials, is nicknamed the Godzilla of weight-loss jabs because of its potential superior efficacy. Developed by Eli Lilly, is a triple hormone 28.7% Weight Loss in New

Application is typically twice daily to the scalp, though once-daily use shows benefit with better compliance for many people

They act on the hypothalamus the brain region that decides whether you're hungry or full and they do it remarkably well

Common symptoms Dull or throbbing head pain Tension around the temples, forehead, or back of the head Sensitivity to light or sound Nausea or fatigue accompanying the headache Headache triggered by hunger, dehydration, or low blood sugar How common are headaches from GLP-1 treatments

Yet the condition is still too often dismissed as a superficial skin problem, meaning patients encounter a lack of understanding and do not receive the right care

10.1507/endocrj.EJ12-0158 81